JP2021523941A5 - - Google Patents

Info

Publication number
JP2021523941A5
JP2021523941A5 JP2021513005A JP2021513005A JP2021523941A5 JP 2021523941 A5 JP2021523941 A5 JP 2021523941A5 JP 2021513005 A JP2021513005 A JP 2021513005A JP 2021513005 A JP2021513005 A JP 2021513005A JP 2021523941 A5 JP2021523941 A5 JP 2021523941A5
Authority
JP
Japan
Prior art keywords
methyl
pyridine
oxy
piperidine
dichlorophenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021513005A
Other languages
English (en)
Japanese (ja)
Other versions
JP7350061B2 (ja
JP2021523941A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/062098 external-priority patent/WO2019215341A1/en
Publication of JP2021523941A publication Critical patent/JP2021523941A/ja
Publication of JP2021523941A5 publication Critical patent/JP2021523941A5/ja
Application granted granted Critical
Publication of JP7350061B2 publication Critical patent/JP7350061B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021513005A 2018-05-11 2019-05-10 フューリンインヒビター Active JP7350061B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862670050P 2018-05-11 2018-05-11
US62/670,050 2018-05-11
PCT/EP2019/062098 WO2019215341A1 (en) 2018-05-11 2019-05-10 Furin inhibitors

Publications (3)

Publication Number Publication Date
JP2021523941A JP2021523941A (ja) 2021-09-09
JP2021523941A5 true JP2021523941A5 (cg-RX-API-DMAC7.html) 2022-05-18
JP7350061B2 JP7350061B2 (ja) 2023-10-02

Family

ID=66597541

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021513005A Active JP7350061B2 (ja) 2018-05-11 2019-05-10 フューリンインヒビター

Country Status (12)

Country Link
US (1) US11773078B2 (cg-RX-API-DMAC7.html)
EP (1) EP3790871B1 (cg-RX-API-DMAC7.html)
JP (1) JP7350061B2 (cg-RX-API-DMAC7.html)
KR (1) KR102823187B1 (cg-RX-API-DMAC7.html)
CN (1) CN112384509B (cg-RX-API-DMAC7.html)
AU (1) AU2019267166C1 (cg-RX-API-DMAC7.html)
BR (1) BR112020022961A2 (cg-RX-API-DMAC7.html)
CA (1) CA3099863A1 (cg-RX-API-DMAC7.html)
IL (2) IL302997B2 (cg-RX-API-DMAC7.html)
MX (1) MX2020012034A (cg-RX-API-DMAC7.html)
SG (1) SG11202010914YA (cg-RX-API-DMAC7.html)
WO (1) WO2019215341A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11202010914YA (en) 2018-05-11 2020-12-30 Glaxosmithkline Ip Dev Ltd Furin inhibitors
WO2021097002A1 (en) * 2019-11-12 2021-05-20 Bp Asset V, Inc. Use of pyridyloxypyrimidines for treating infectious diseases
WO2021097008A1 (en) * 2019-11-12 2021-05-20 Bp Asset V, Inc. Use of pyridyloxypyridines for treating infectious diseases
JP2023503852A (ja) * 2019-11-12 2023-02-01 ビーピー アセット ヴイ,インコーポレーテッド 感染症を処置するための低分子フーリン阻害剤
JP2023521032A (ja) * 2020-04-02 2023-05-23 ビーピー アセット ヴイ,インコーポレーテッド コロナウイルス感染症を処置するためのフーリンインヒビター
FR3110345B1 (fr) 2020-05-21 2024-03-29 Agence Francaise Pour Le Dev D’Al Ula Hydrolysat de protéines du tourteau des graines de Moringa peregrina pour son application en tant que médicament, son procédé d’obtention et compositions pharmaceutiques, dermatologiques et cosmétiques.
CN117222410A (zh) * 2021-02-03 2023-12-12 Bp资产V股份有限公司 用于吸入的弗林蛋白酶抑制剂的制剂
CN114853640A (zh) * 2022-05-12 2022-08-05 马鞍山昂扬新材料科技有限公司 2-溴乙基磺酸钠的制备方法
EP4594312A1 (en) * 2022-09-29 2025-08-06 BP Asset V, Inc. 4-((2-(3,5-dichlorophenyl)-6-((pyrimidin-5-yl)oxy)pyridin-4-yl)methyl)piperazine derivatives as furin inhibitors and uses thereof
DE102023126563A1 (de) * 2023-09-28 2025-04-03 Philipps-Universität Marburg, Körperschaft des öffentlichen Rechts Hemmstoffe der Proproteinkonvertase Furin, Verfahren zu deren Herstellung und Verwendung
CN119119096B (zh) * 2024-09-09 2025-09-16 郑州药领医药科技有限公司 一种4-((4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)甲基)哌啶-1-甲酸叔丁酯的合成方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY147019A (en) 2002-03-13 2012-10-15 Biogen Idec Inc Anti-alpha v beta 6 antibodies
DK2316831T3 (da) 2002-11-21 2013-06-10 Novartis Ag 2-(Morpholin-4-yl)pyrimidiner som phosphotidylinositol (PI)-3-kinaseinhibitorer samt deres anvendelse ved behandling af cancer
WO2005047268A2 (en) 2003-11-10 2005-05-26 X-Ceptor Therapeutics, Inc. Substituted pyrimidine compositions and methods of use
EP1799244A4 (en) * 2004-07-23 2010-06-09 Smith Judith INHIBITORS OF FURINE
WO2006031852A1 (en) * 2004-09-13 2006-03-23 Amgen Inc. Vanilloid receptor ligands and their use in treatments
CA2687024A1 (en) 2007-05-09 2009-02-19 Burnham Institute For Medical Research Targeting host proteinases as a therapeutic strategy against viral and bacterial pathogens
KR101247840B1 (ko) * 2008-02-22 2013-03-26 에프. 호프만-라 로슈 아게 아밀로이드 베타 조절제
HRP20171587T1 (hr) 2010-10-18 2017-12-01 Cerenis Therapeutics Holding Sa Spojevi, pripravci i postupci pogodni za mobilizaciju kolesterola
WO2013138665A1 (en) * 2012-03-16 2013-09-19 Sanford-Burnham Medical Research Institute Inhibitors of furin and other pro-protein convertases
US20150051138A1 (en) 2012-03-16 2015-02-19 Sanford-Burnham Medical Research Institute Inhibitors of furin and other pro-protein convertases
EP2884982B1 (en) 2012-08-20 2017-09-20 Merck Sharp & Dohme Corp. SUBSTITUTED PHENYL SPLEEN TYROSINE KINASE (Syk) INHIBITORS
US10150742B2 (en) 2013-03-15 2018-12-11 President And Fellows Of Harvard College Substituted heterocyclic compounds for treating or preventing viral infections
US10766860B2 (en) * 2015-03-06 2020-09-08 Pharmakea, Inc. Lysyl oxidase-like 2 inhibitors and uses thereof
CN107441094B (zh) 2017-08-08 2020-05-22 南方医科大学 尼罗替尼作为治疗登革病毒感染的药物及其制药用途
SG11202010914YA (en) 2018-05-11 2020-12-30 Glaxosmithkline Ip Dev Ltd Furin inhibitors
JP2023503852A (ja) 2019-11-12 2023-02-01 ビーピー アセット ヴイ,インコーポレーテッド 感染症を処置するための低分子フーリン阻害剤

Similar Documents

Publication Publication Date Title
IL278642B1 (en) Purine inhibitors
NL2000323C2 (nl) Pyrimidine-derivaten.
ES2654051T3 (es) Pirrolo[2,3-d]pirimidinilo, pirrolo[2,3-b]pirazinilo y pirrolo[2,3-d]piridinil acrilamidas
EP3183247B9 (en) Aminopyrimidinyl compounds as jak inhibitors
ES2534335T3 (es) Compuestos macrocíclicos como inhibidores de la Trk cinasa
JP6585158B2 (ja) ヤヌスキナーゼの阻害に有用なピロロ[2,3−d]ピリミジン誘導体
JP5629324B2 (ja) ピロロ[2,3−d]ピリミジン化合物
TW202523297A (zh) 用於治療癌症的咪唑並嘧啶化合物
RU2399620C2 (ru) Производные хинуклидина и их применение в качестве антагонистов мускариновых рецепторов м3
ES2590929T3 (es) Derivados de bencilsulfonamida útiles como inhibidores de MOGAT-2
JP2013514356A (ja) ピロロ[2,3−d]ピリミジン化合物
RS63981B1 (sr) Selektivni inhibitori jak1
JP2023552864A5 (cg-RX-API-DMAC7.html)
JP2018536684A (ja) ブルトン型チロシンキナーゼの阻害剤及びその使用方法
CN114746414A (zh) 氮杂-喹啉化合物及其用途
JP2017519023A (ja) 3−置換2−アミノ−インドール誘導体
US20230373935A1 (en) Modulators of cystic fibrosis transmembrane conductance regulator
WO2024259171A9 (en) Keap1 inhibitors and uses thereof
TW202233622A (zh) 用於治療疾病之雙環化合物及其用途
JP2023503852A5 (cg-RX-API-DMAC7.html)
JP2023521032A5 (cg-RX-API-DMAC7.html)
RU2020140798A (ru) Ингибиторы фурина
US12257243B2 (en) 5-hydroxy-7-oxabicyclo[2.2.1]heptane-2-carboxamide derivatives for inducing chondrogenesis for treating joint damage
HK40077297A (en) Aza-quinoline compounds and uses thereof
EP4727945A1 (en) 3-[3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]-3,8-diazabicyclo[3.2.1]octane derivatives as smarca2 degrading protacs for the treatment of cancer